Zafgen Appoints Industry Executive Dennis Kim, M.D., M.B.A., to Chief Medical Officer  
9/21/2011 10:38:05 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced the appointment of Dennis Kim, M.D., M.B.A., to the position of chief medical officer. In this newly created position, Dr. Kim will assume primary responsibility for Zafgen’s clinical development, including clinical and regulatory strategy, trial design and oversight of the company’s virtual clinical team.